Flerie AB

M&A Activity • Apr 4, 2025

Flerie sells Toleranzia shares to long-term Flerie investors

Stockholm, Sweden, April 4, 2025. Flerie AB announces the divestment of 35,764,705 shares in the portfolio company Toleranzia for a total consideration of SEK 15.2 million. After the divestment, Flerie holds 143,884,105 million shares in Toleranzia.

Following the divestment, Flerie's ownership in Toleranzia amounts to approximately 53.10 per cent.

On March 25, Flerie and Toleranzia announced a merger plan to take Toleranzia private. The merger is conditional upon approvals at extraordinary general meetings in both companies.

"Following the launch of the merger plan with Toleranzia, we have experienced significant interest from long-term investors in pursuing the opportunity to increase their holdings in Flerie at a discount by acquiring shares in Toleranzia. We welcome this interest that has now materialised into the transactions announced today," says Ted Fjällman, CEO of Flerie AB.

For more information:

Ted Fjällman, CEO Email: ir@flerie.com

Flerie in brief

Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie's active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB's ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com

Attachments

Flerie sells Toleranzia shares to long-term Flerie investors